Language: 中文 | English
In January

Shenzhen HYK Gene Technology Co., Ltd. was founded;

In September

the Group rolled out the first-generation homemade PSTAR-I high-throughput gene sequencing system;

< >
In April

Dr. Sheng Sitong was selected into the first batch of “The Thousand Talents Program” introduced by the State;

In May

the Group realized localization of sequencing reagents;

In October

the Group was awarded an honorary title of “Key Entrepreneur Team of Overseas Chinese Run Enterprise” by the Overseas Chinese Affairs Office of the State Council;

In November

the Group was awarded the honorary title of “Demonstrative Base for Production-Academy-Research Integration of Ministries of Education and Science in Guangdong Province”;

< >
In February

the Group was awarded the honorary title of “Key Overseas Scientific Research and Innovation Team Introduced by Guangdong Province”;

In June

the Group successfully developed the second-generation homemade PSTAR-II high-throughput gene sequencing system;

In August

the “high-throughput gene sequencer” was certified as a “National Key New Product”;

the Group set up a “Post-doctor Work Station”;

In October

the “Engineering Technology Center of High-throughput Gene Sequencing” of Shenzhen was established;

In November

the Group was awarded the honorary title of “Demonstrative Base for Production-Academy-Research Integration of Ministries of Education and Science in Guangdong Province”;


< >
In June

HYK Gene acted as the leader unit of the first standardization work team in the field of gene sequencing-“Biological Method Team of National Commission of Bio-chemical Test Standardization Technology” (SAC/TC387/WG3);

In August

the Group rolled out PSTAR-II A type gene sequencer for clinical application;

The Group successfully developed PSTAR-II plus high-throughput gene sequencing system;


< >
In January

the Group was approved to establish an “Academician Workstation of Microorganism Gene Analysis Technology of Shenzhen HYK of Guangdong”;

The Group was granted with a Medical Device Manufacturing Enterprise License;

In August

the sequencing platform was granted with a Registration Certificate for Medical Devices;

The Group was certified as a “National High-tech Enterprise”;

< >
In September

five sequencing devices were granted with the Registration Certificate for Medical Devices;

The Group successfully developed SeqExpert-III A high-throughput gene sequencing system;


< >
In June

the first homemade gene sequencer HYK-PSTAR II-A was rated among the first batch of products to pass “Special Review for Innovative Medical Devices” of the State.

In June

the first national standard in the field of gene sequencing in China, Technical Regulations of High-throughput Gene Sequencing, initiated by HYK Gene, was officially released.

In November

the National 863 Program organized by HYK Gene was officially launched.

In December

HYK-PSTAR II-A type gene sequencer was granted with the Registration Certificate for Medical Devices.


< >
In August

Human’s EGFR Gene Mutation Test Reagent Kit (High-throughput Sequencing Method) passed the special review for innovative medical devices;

In September

Wuhan Considerin Gene Health Technology Co., Ltd. under the Group was established;

In October

Central China Base for Equipment and Reagent R&D and Production was settled in Wuhan Optics Valley.

In December

Guangzhou Considerin Med Lab was granted with a Business Permit for Medical Institution.


< >
In March

Dr. Sheng Sitong, the Group’s chief scientist, was honored as a national leading talent of “Urban Partner of Wuhan”;

In April

the Group signed a strategic alliance cooperation agreement with Vishuo in Singapore to co-build a model of “gene sequencing+ precision medicine data” and started its international cooperation;

In June

HYK-PSTAR-IIA type high-throughput gene sequencer and sample pre-treatment device passed CE certification;


< >